Shijiazhuang No.4 Pharmaceutical has obtained the drug production registration approval for Pulsatilla Succinate Tablets.
Category:
Time:2020-07-27
Recently, Shijiazhuang Sihua Pharmaceutical Co., Ltd. obtained drug registration certificates from the National Medical Products Administration for Pulsatilla succinate tablets (1mg and 2mg).
Recently, Shijiazhuang No.4 Pharmaceutical Co., Ltd. obtained drug registration certificates from the National Medical Products Administration for Pulsatilla succinate tablets (1 mg and 2 mg).
The succinate prucalopride tablets (1 mg and 2 mg) recently approved were submitted under Category 4 of the chemical drug registration classification and, upon approval, will be deemed to have passed the consistency evaluation. Shijiazhuang Fourth Pharmaceutical is one of only three domestic companies that have already passed the consistency evaluation for this product.
It was introduced that Prucalopride Succinate Tablets are primarily used to treat symptoms of chronic constipation.
Keywords:
Recommended News
SERVICE HOTLINE
Mobile site
E code
Business license